Study detail
RecruitingPhase 1
A Single-Arm, Blinded, Fluorescent PSMA Histopathology Trial of AS1986NS
Antelope Surgical Solutions, Inc
Summary
A Single-Arm, blinded, fluorescent PSMA histopathology trial of AS1986NS
Eligibility
- Age range
- 18–90 years
- Sex
- Male
- Healthy volunteers
- No
Detailed criteria
Inclusion Criteria: * suspected prostate cancer warranting standard of care multi-core prostate biopsy Exclusion Criteria: * Patients receiving same-day therapeutic Lutetium-177 or Actinium-225 PSMA receptor radiation isotope therapy treatment * Patients with pre-existing, impaired or abnormal hepatic function, renal function, cardiac function, and abnormal elevated temperature * Patients with a creatinine clearance cutoff (CrCl) of \< 60 mL/min
Interventions
- DrugAS1986NS
Single dose, IV, 100 µg of AS1986NS
Locations (3)
- HCA Florida Kendall HospitalMiami, Florida
- Icahn School of Medicine at Mount Sinai (ISMMS)New York, New York
- Linkou Chang Gung Memorial HospitalTaoyuan City, Taiwan